Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 12;11(8):1094.
doi: 10.3390/antibiotics11081094.

New Pyrazolo-Benzimidazole Mannich Bases with Antimicrobial and Antibiofilm Activities

Christina Zalaru  1 , Florea Dumitrascu  2 , Constantin Draghici  2 , Isabela Tarcomnicu  3   4 , Maria Marinescu  1 , George Mihai Nitulescu  5 , Rodica Tatia  6 , Lucia Moldovan  6 , Marcela Popa  7 , Mariana Carmen Chifiriuc  7   8
Affiliations

New Pyrazolo-Benzimidazole Mannich Bases with Antimicrobial and Antibiofilm Activities

Christina Zalaru et al. Antibiotics (Basel). .

Abstract

A new series of pyrazolo-benzimidazole hybrid Mannich bases were synthesized, characterized by 1H-NMR, 13C-NMR, IR, UV-Vis, MS, and elemental analysis. In vitro cytotoxicity of the new compounds studied on fibroblast cells showed that the newly synthesized pyrazolo-benzimidazole hybrid derivatives were noncytotoxic until the concentration of 1 μM and two compounds presented a high degree of biocompatibility. The antibacterial and antibiofilm activity of the newly synthesized compounds was assayed on Gram-positive Staphylococcus aureus ATCC25923, Enterococcus faecalis ATCC29212, and Gram-negative Pseudomonas aeruginosa ATCC27853, Escherichia coli ATCC25922 strains. All synthesized compounds 5a-g are more active against all three tested bacterial strains Staphylococcus aureus ATCC25923, Enterococcus faecalis ATCC29212, and Escherichia coli ATCC25922 than reference drugs (Metronidazole, Nitrofurantoin), with the exception of compounds 5d and 5g, which are less active compared to Nitrofurantoin, and all synthesized compounds 5a-g are more active against Pseudomonas aeruginosa ATCC27853 compared to reference drugs (Metronidazole, Nitrofurantoin). Compound 5f showed the best activity against Staphylococcus aureus ATCC 25923, with a MIC of 150 μg/mL and has also inhibited the biofilm formed by all the bacterial strains, having an MBIC of 310 µg/mL compared to the reference drugs (Metronidazole, Nitrofurantoin).

Keywords: antimicrobial; benzimidazoles; biofilm formation; cytotoxicity; hybrid heterocyclic molecules; pyrazoles.

PubMed Disclaimer

Conflict of interest statement

The authors confirm that this article’s content has no conflict of interest.

Figures

Figure 1
Figure 1
Drugs containing pyrazole ring.
Figure 2
Figure 2
Drugs containing benzimidazole ring.
Scheme 1
Scheme 1
Synthesis of substituted pyrazoles. Reagents: acetylacetone, hydrazine hydrate (1b); (i) HNO3/H2SO4 (1c);(ii) I2/KI, AcONa (1d); (iii) CH2O, MeOH (2a–d).
Scheme 2
Scheme 2
Synthesis of substituted benzimidazoles and 1-amino-1H-benzimidazoles derivatives. Reagents: (iv) o-phenylenediamine, carboxylic acids, reflux. (3a,b); (v). HOSA (4a,b). R = H (3a, 4a); R = CH3 (3b, 4b).
Scheme 3
Scheme 3
Synthesis ofsubstituted pyrazolo-benzimidazoles 5a–g. Reagents (vi) CH2Cl2, R = H, CH3.
Scheme 4
Scheme 4
The mechanism of the Mannich reaction.
Scheme 5
Scheme 5
The fragmentation process for compounds 5a–c.
Scheme 6
Scheme 6
The fragmentation process for compounds 5d–g.
Figure 3
Figure 3
Cell viability of L929 fibroblasts cultured with pyrazolo-benzimidazole derivatives after 48h of experimentation, evaluated by MTT assay.
Figure 4
Figure 4
Molecular structure of reference drugs.
Figure 5
Figure 5
MIC (μg/mL) values of the tested compounds.
Figure 6
Figure 6
MIBC (μg/mL) values of the tested compounds.
See this image and copyright information in PMC

References

    1. Reddy T.S., Kulhari H., Reddy V.G., Bansal V., Kamal A., Shukla R. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Eur. J. Med. Chem. 2015;101:790–805. doi: 10.1016/j.ejmech.2015.07.031. - DOI - PubMed
    1. Marinescu M., Zalaru C.M. Synthesis, Antibacterial and Anti-Tumor Activity of Pyrazole Derivatives. In: MedDocs eBooks, editor. Recent Trends in Biochemistry. MedDocs Publishers LLC; Reno, NV, USA: 2021. [(accessed on 1 January 2020)]. pp. 18–27. Chapter 3. Available online: http://meddocsonline.org/
    1. Kumar V., Kaur K., Gupta G.K., Sharma A.K. Pyrazole containing natural products: Synthetic preview and biological significance. Eur. J. Med. Chem. 2013;69:735–753. doi: 10.1016/j.ejmech.2013.08.053. - DOI - PubMed
    1. Caliskan B., Yilmaz A., Evren I., Menevse S., Uludag O., Banoglu E. Synthesis and evaluation of analgesic, anti-inflammatory, and anticancer activities of new pyrazole-3(5)-carboxylic acid derivatives. Med. Chem. Res. 2013;22:782–793. doi: 10.1007/s00044-012-0072-4. - DOI
    1. Gokhan-Kelekci N., Koyunoglu S., Yabanoglu S., Yelekci K., Ozgen O., Ucar G., Erol K., Kendi E., Yesilada A. New pyrazoline bearing, 4(3H)-quinazolinone inhibitors of monoamine oxidase: Synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity. Bioorg. Med. Chem. 2009;17:675–689. doi: 10.1016/j.bmc.2008.11.068. - DOI - PubMed

LinkOut - more resources